Biologic on Par With OIT for Turning Allergy-Forbidden Foods Into Everyday Eats

(MedPage Today) — PHILADELPHIA — Most multi-food allergic children succeeded in longer term regular dietary consumption whether treated with oral immunotherapy (OIT) or omalizumab (Xolair) alone, results from stage 3 of the OUtMATCH trial showed…